P. Smolak

发表

Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo

C. Rauch, T. Griffith, H. Walczak, 1999, Nature Medicine.

Safety, pharmacokinetics, and pharmacodynamics of RSLV-132, an RNase-Fc fusion protein in systemic lupus erythematosus: a randomized, double-blind, placebo-controlled study

P. Smolak, R. Levin, R. Martin, 2017, Lupus.

Functional analysis of TRAIL receptors using monoclonal antibodies.

C. Smith, C. Rauch, N. Boiani, 1999, Journal of immunology.

Characterization of the in vivo function of TNF‐α‐related apoptosis‐inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene‐deficient mice

L. Sedger, S. Kanaly, B. Gliniak, 2002, European journal of immunology.

Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.

C. Smith, M. Degli-Esposti, P. Smolak, 1997, Journal of immunology.

Discovery and Optimization of Triazolopyrimidinone Derivatives as Selective NLRP3 Inflammasome Inhibitors.

M. Bock, C. Gabel, M. Holloway, 2022, ACS medicinal chemistry letters.

Using Monoclonal Antibodies Functional Analysis of TRAIL Receptors

C. Rauch, N. Boiani, T. Griffith, 1999 .

Identification and characterization of a new member of the TNF family that induces apoptosis.

C A Smith, C. Smith, G. Sutherland, 1995, Immunity.

Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family

R. Dubose, M. Degli-Esposti, H. Walczak, 1997, The Journal of experimental medicine.

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain.

C. Smith, W. Dougall, M. Degli-Esposti, 1997, Immunity.

Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha.

C. Smith, C. Richards, P. Smolak, 1996, Virology.

TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL

Henning Walczak, M. Gerhart, M. Degli-Esposti, 1997, The EMBO journal.

Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors.

M. Gerhart, C. Smith, D. Friend, 1997, Virology.

A Novel Highly Potent Therapeutic Antibody Neutralizes Multiple Human Chemokines and Mimics Viral Immune Modulation

Ryan L. Kelly, T. Foy, M. Scalley‐Kim, 2012, PloS one.

Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus.

D. Wiley, C. Smith, A. Carfi, 1999, Proceedings of the National Academy of Sciences of the United States of America.

TRAIL-R 2 : a novel apoptosis-mediating receptor for TRAIL et al . , 1980 ) and , together with cell proliferation , governs

M. Gerhart, A. Schooley, Richard S. Johnson, 2013 .

Cloning and Characterization of Trail-r3, a Novel Member of the Emerging Trail Receptor Family Materials and Methods

R. Dubose, M. Degli-Esposti, P. Smolak, 1997 .